Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer
Yoshinaga Okugawa(Mie University), Masato Kusunoki(Mie University), Hiroyuki Fujikawa(Mie University), Akira Yamamoto(Mie University), Junichiro Hiro(Mie University), Yuji Toiyama(Mie University), Chengzeng Yin(Mie University), Takashi Ichikawa(ETH Zurich), Donald C. McMillan(University of Glasgow), Akihiro Suzuki(St. Luke's International Hospital), Toshimitsu Araki(Mie University), Shigeyuki Yoshiyama(Mie University), Masaki Ohi(Mie University), Hiromi Yasuda(Mie University), Tsunehiko Shigemori(Mie University)
Cited by 144
Related Papers
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
|Gastroenterology|2015|814
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
|British Journal of Cancer|2011|526
Readily Available Biaryl P,N Ligands for Asymmetric Catalysis
|Angewandte Chemie International Edition|2004|378
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
|Annals of Surgical Oncology|2009|324